Wong, Raymond <br/><br/>
PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Oct 2014 
 - 13371-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Standard No.: </label>10.1523/JNEUROSCI.1008-14.2014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Benzimidazoles--pharmacology<br/>Calcium--metabolism<br/>Calcium Channel Agonists--pharmacology<br/>Calcium Signaling--physiology<br/>Calcium-Calmodulin-Dependent Protein Kinases--metabolism<br/>Calmodulin--metabolism<br/>Cells, Cultured<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>HEK293 Cells<br/>Humans<br/>Intermediate-Conductance Calcium-Activated Potassium Channels--genetics<br/>Male<br/>Membrane Potentials--drug effects<br/>Protein Binding--drug effects<br/>Protein Kinases--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Serine--metabolism